OKUR insider trading — OnKure Therapeutics, Inc.
Over the last 90 days, insiders at OnKure Therapeutics, Inc. (OKUR) made 0 open-market purchases worth $0 and 2 open-market sales worth $1K, making them net sellers by $1K. The largest sale was by Leverone Jason A. (Chief Financial Officer), who sold 302 shares for $898 on Sep 21, 2026.
Updated Oct 16, 2026.
Recent OKUR insider transactions
Every Form 4 filed by OnKure Therapeutics, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Saccomano Nicholas A | President and CEO | S · Sale | Direct | 87 | $2.97 | $259 | Form 4 |
| Sep 21, 2026 | Leverone Jason A. | Chief Financial Officer | S · Sale | Direct | 302 | $2.97 | $898 | Form 4 |
OKUR insider trading FAQ
Are insiders buying OKUR stock?
Not on the open market. In the last 90 days, OnKure Therapeutics, Inc. insiders made no open-market purchases, and 2 open-market sales totaling $1K. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading OKUR?
Recent sellers: Leverone Jason A., Saccomano Nicholas A.
Where does OKUR insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.